Bryan Richard  Hinton net worth and biography

Bryan Hinton Biography and Net Worth

Bryan Hinton joined Health Catalyst in 2012 and currently serves as the Chief Technology Officer. He has been instrumental in the development and integration of the Health Catalyst Data Operating System (DOS™)—Health Catalyst’s primary technology platform. Prior to joining Health Catalyst, Bryan spent 4 years with The Church of Jesus Christ of Latter-Day Saints and 7 years with Intel. While at the LDS Church, he led the .NET Development Center of Excellence and was responsible for setting the architectural guidance of all .NET projects across the company. As a senior software engineer at Intel, he was responsible for the development and implementation of Intel’s factory data warehouse product that was installed at Intel factories worldwide.

Bryan carries a deep technical experience and understanding across all facets of software engineering with an emphasis on adopting software engineering practices as part of the data engineering process. He is passionate about building software and creating healthy engineering environments and teams. He believes deeply that curiosity and continuous learning are necessary skills to be fostered and encouraged for a successful team, and is an advocate for a healthy work-life balance.

Bryan graduated from Brigham Young University in Provo, UT with a BS in Computer Science.

What is Bryan Richard Hinton's net worth?

The estimated net worth of Bryan Richard Hinton is at least $126,822.96 as of September 7th, 2021. Mr. Hinton owns 21,032 shares of Health Catalyst stock worth more than $126,823 as of April 26th. This net worth evaluation does not reflect any other assets that Mr. Hinton may own. Learn More about Bryan Richard Hinton's net worth.

How do I contact Bryan Richard Hinton?

The corporate mailing address for Mr. Hinton and other Health Catalyst executives is 3165 MILLROCK DRIVE SUITE 400, SALT LAKE CITY UT, 84121. Health Catalyst can also be reached via phone at (801) 708-6800 and via email at [email protected]. Learn More on Bryan Richard Hinton's contact information.

Has Bryan Richard Hinton been buying or selling shares of Health Catalyst?

Bryan Richard Hinton has not been actively trading shares of Health Catalyst over the course of the past ninety days. Most recently, Bryan Richard Hinton sold 106 shares of the business's stock in a transaction on Monday, January 3rd. The shares were sold at an average price of $39.76, for a transaction totalling $4,214.56. Learn More on Bryan Richard Hinton's trading history.

Who are Health Catalyst's active insiders?

Health Catalyst's insider roster includes Jason Alger (CAO), Daniel Burton (CEO), Bryan Hinton (CTO), Paul Horstmeier (COO), Bryan Hunt (CFO), Linda Llewelyn (Insider), James Nelli, Jr. (President), Daniel Orenstein (CEO), and Anita Pramoda (Director). Learn More on Health Catalyst's active insiders.

Are insiders buying or selling shares of Health Catalyst?

During the last year, Health Catalyst insiders bought shares 1 times. They purchased a total of 49,050 shares worth more than $499,819.50. During the last year, insiders at the sold shares 12 times. They sold a total of 19,034 shares worth more than $194,837.29. The most recent insider tranaction occured on April, 15th when insider Linda Llewelyn sold 2,005 shares worth more than $12,250.55. Insiders at Health Catalyst own 2.7% of the company. Learn More about insider trades at Health Catalyst.

Information on this page was last updated on 4/15/2024.

Bryan Richard Hinton Insider Trading History at Health Catalyst

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/3/2022Sell106$39.76$4,214.56View SEC Filing Icon  
12/27/2021Sell260$39.56$10,285.60View SEC Filing Icon  
12/6/2021Sell6,457$38.43$248,142.51View SEC Filing Icon  
12/3/2021Sell105$42.87$4,501.35View SEC Filing Icon  
11/26/2021Sell260$44.10$11,466.00View SEC Filing Icon  
11/3/2021Sell106$52.62$5,577.72View SEC Filing Icon  
10/25/2021Sell260$50.66$13,171.60View SEC Filing Icon  
10/4/2021Sell106$49.00$5,194.00View SEC Filing Icon  
9/27/2021Sell260$53.41$13,886.60View SEC Filing Icon  
9/7/2021Sell2,176$54.90$119,462.4021,032View SEC Filing Icon  
9/3/2021Sell106$54.23$5,748.3821,032View SEC Filing Icon  
8/25/2021Sell260$53.13$13,813.8022,135View SEC Filing Icon  
8/10/2021Sell4,020$54.32$218,366.4024,595View SEC Filing Icon  
See Full Table

Bryan Richard Hinton Buying and Selling Activity at Health Catalyst

This chart shows Bryan Richard Hinton's buying and selling at Health Catalyst by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Health Catalyst Company Overview

Health Catalyst logo
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Read More

Today's Range

Now: $6.03
Low: $5.53
High: $6.07

50 Day Range

MA: $7.39
Low: $5.53
High: $9.83

2 Week Range

Now: $6.03
Low: $5.45
High: $14.37

Volume

692,620 shs

Average Volume

616,318 shs

Market Capitalization

$353.12 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.29